OK
Cancel
close

You must be signed in to use this feature.

SIGN IN or REGISTER


CHABNER COLLOQUIUM AND 2017 STO ANNUAL MEETING

Abstract Book


Session 1:
New Insights into DNA Repair and Drug Response

2:24


Targeting the ATR Kinase in Cancer Therapy Lee Zou, PhD
Video Interview | Lecture: Audio/Slides

4:35

PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian CancerAlan D’Andrea, MD
Video Interview

2:56

Assessing DNA Repair in Clinical TrialsTed Hong, MD
Video Interview | Lecture: Audio/Slides


Session 2: Targets That Defy Effective Therapy

1:48

Developing Therapies for Ras-driven Cancers Karen Cichowski, PhD
Video Interview | Lecture: Audio

3:07

Is FGFR Inhibition an Effective Target in Gastrointestinal Tumors?Lipika Goyal, MD
Video Interview | Lecture: Audio/Slides

2:15

Intergenic Fusions in Advanced HR+ Breast CancerLeif Ellisen, MD, PhD
Video Interview | Lecture: Audio/Slides


Session 3: Promising Drug-antibody Conjugates and Cell Death Pathway Inhibitors

4:05

Genomic and Functional Characterization of Patient Derived Xenograft Models of Small Cell Lung CancerAnna Farago, MD, PhD
Video Interview | Lecture: Audio/Slides

4:18

Antibody Drug Conjugates for Triple Negative Breast Cancer: Targeting Positive in the NegativeAditya Bardia, MD, MPH
Video Interview | Lecture: Audio/Slides

2:47

PARP in Breast CancerSteven J. Isakoff, MD, PhD
Video Interview | Lecture: Audio/Slides


Session 4: Junior Faculty Forum

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor
Spheroids
Russell Jenkins, MD, PhD
Lecture: Audio/Slides


Financial Toxicity of CancerRyan Nipp, MD, MPH
Lecture: Audio/Slides


Improving Therapy for EGFR-Mutant Lung CancersZosia Piotrowska, MD
Lecture: Audio/Slides






2017 Acknowledgments

The Society for Translational Oncology gratefully acknowledges educational grants in partial support of this activity from:

Amgen
EcoR1 Capital
Lilly
Novartis
Pfizer